Quarterly report [Sections 13 or 15(d)]

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in- Capital
Treasury Stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning balance at Dec. 28, 2024 $ 61 $ 325,546 $ (11,912) $ 1,055 $ (229,575) $ 85,175
Beginning balance (in shares) at Dec. 28, 2024 57,454          
Increase (Decrease) in Stockholders' Equity            
Net loss         (15,283) (15,283)
Issuance of shares in connection with restricted stock units vesting $ 1 (396)       (395)
Issuance of shares in connection with restricted stock units vesting (in shares) 715          
Issuance of shares in connection with BOD fees   11       11
Issuance of shares in connection with BOD fees (in shares) 11          
Officers and directors stock purchase plan (in shares) 1          
Issuance of shares in connection with ESPP   96       96
Issuance of shares in connection with ESPP (in shares) 114          
Share-based compensation   3,166       3,166
Ending balance at Mar. 29, 2025 $ 62 328,423 (11,912) 1,055 (244,858) 72,770
Ending balance (in shares) at Mar. 29, 2025 58,295          
Beginning balance at Jan. 03, 2026 $ 65 344,118 (11,912) 1,223 (280,018) 53,476
Beginning balance (in shares) at Jan. 03, 2026 70,048          
Increase (Decrease) in Stockholders' Equity            
Net loss         (1,940) (1,940)
Issuance of shares in connection with restricted stock units vesting   (77)       (77)
Issuance of shares in connection with restricted stock units vesting (in shares) 409          
Issuance of shares in connection with BOD fees   12       12
Issuance of shares in connection with BOD fees (in shares) 21          
Issuance of shares in connection with equity purchase agreement $ 10 7,990       8,000
Issuance of shares in connection with equity purchase agreement (in shares) 10,000          
Issuance costs in connection with equity purchase agreement   (36)       (36)
Share-based compensation   1,395       1,395
Deconsolidation from the sale of subsidiary       $ (1,223)   (1,223)
Ending balance at Apr. 04, 2026 $ 75 $ 353,402 $ (11,912)   $ (281,958) $ 59,607
Ending balance (in shares) at Apr. 04, 2026 80,478